| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF18A MYH3 ABCA1 ERCC3 VPS4B ABCC11 BTAF1 OLA1 DDX11 ATP2C2 DHX29 FIGNL1 DDX11L8 | 6.57e-05 | 441 | 162 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | transketolase activity | 1.95e-04 | 3 | 162 | 2 | GO:0004802 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 3.88e-04 | 4 | 162 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | DNA replication origin binding | 3.91e-04 | 18 | 162 | 3 | GO:0003688 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 4.40e-04 | 44 | 162 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | cadherin binding | 4.62e-04 | 339 | 162 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF18A MYH3 ABCA1 ERCC3 VPS4B ABCC11 BTAF1 OLA1 DDX11 ATP2C2 ATP6V1C2 DHX29 FIGNL1 DDX11L8 | 4.94e-04 | 614 | 162 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 5.18e-04 | 172 | 162 | 7 | GO:0008757 | |
| GeneOntologyMolecularFunction | actin binding | KIF18A FLNA MYH3 FLNC SPATA31A3 SPATA31A7 HIP1R SPATA31A5 SPATA31A1 BAIAP2L1 EGFR TNNT3 | 5.53e-04 | 479 | 162 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | thiolester hydrolase activity | 5.67e-04 | 47 | 162 | 4 | GO:0016790 | |
| GeneOntologyMolecularFunction | transketolase or transaldolase activity | 6.44e-04 | 5 | 162 | 2 | GO:0016744 | |
| GeneOntologyBiologicalProcess | male gamete generation | TDRD5 KIF18A SPATA31A3 ARMC3 STRBP SPATA31A7 APOB SPATA31A5 SPATA31D1 LIMK2 SPATA31A1 BRD2 BRCA2 SEC23IP POC1B CDY2A FAM9A FIGNL1 TARBP2 | 7.47e-06 | 762 | 160 | 19 | GO:0048232 |
| HumanPheno | Overlapping fingers | 3.93e-07 | 35 | 44 | 6 | HP:0010557 | |
| HumanPheno | Hypertelorism | FLNA MYH3 PSAT1 ERCC3 EMC1 NSD1 TOGARAM1 RREB1 CBL YWHAE POLR3A HIRA GREB1L NBAS BMP4 SETD2 UBE2T BRCA2 SETBP1 | 2.10e-05 | 830 | 44 | 19 | HP:0000316 |
| HumanPheno | Elevated circulating apolipoprotein A-II concentration | 7.29e-05 | 2 | 44 | 2 | HP:0031800 | |
| HumanPheno | Increased circulating apolipoprotein circulation | 7.29e-05 | 2 | 44 | 2 | HP:0033460 | |
| HumanPheno | Long foot | 8.53e-05 | 28 | 44 | 4 | HP:0001833 | |
| HumanPheno | Short neck | FLNA MYH3 PSAT1 RREB1 CBL YWHAE MADD POLR3A HIRA NBAS SETBP1 TNNT3 | 9.24e-05 | 398 | 44 | 12 | HP:0000470 |
| HumanPheno | Abnormality of the liver | FLNC ABCA1 NSD1 GBE1 MECOM TOGARAM1 APOB CD46 RREB1 GDF2 CBL NPHP4 HNRNPA2B1 MADD POLR3A HIRA NBAS UBE2T BRCA2 TKT LPL SETBP1 | 1.22e-04 | 1205 | 44 | 22 | HP:0001392 |
| HumanPheno | Narrow mouth | 1.35e-04 | 234 | 44 | 9 | HP:0000160 | |
| HumanPheno | Syndactyly | FLNA MYH3 PSAT1 NSD1 MECOM POLR3A DDX11 NBAS BMP4 UBE2T BRCA2 SETBP1 | 1.45e-04 | 417 | 44 | 12 | HP:0001159 |
| HumanPheno | Pointed chin | 1.52e-04 | 138 | 44 | 7 | HP:0000307 | |
| HumanPheno | Malar flattening | 1.64e-04 | 240 | 44 | 9 | HP:0000272 | |
| HumanPheno | Craniosynostosis | 1.81e-04 | 190 | 44 | 8 | HP:0001363 | |
| HumanPheno | Abnormal malar bone morphology | 2.17e-04 | 249 | 44 | 9 | HP:0012369 | |
| HumanPheno | Long phalanx of finger | 2.18e-04 | 3 | 44 | 2 | HP:0006155 | |
| HumanPheno | Abnormal zygomatic arch morphology | 2.24e-04 | 250 | 44 | 9 | HP:0005557 | |
| HumanPheno | Abnormal zygomatic bone morphology | 2.24e-04 | 250 | 44 | 9 | HP:0010668 | |
| HumanPheno | Abnormality of the cervical spine | FLNA MYH3 PSAT1 RREB1 CBL YWHAE MADD POLR3A HIRA NBAS SETBP1 TNNT3 | 2.36e-04 | 439 | 44 | 12 | HP:0003319 |
| HumanPheno | Polyhydramnios | 2.46e-04 | 312 | 44 | 10 | HP:0001561 | |
| HumanPheno | Abnormal enteric ganglion morphology | 2.56e-04 | 150 | 44 | 7 | HP:0004362 | |
| HumanPheno | Aganglionic megacolon | 2.56e-04 | 150 | 44 | 7 | HP:0002251 | |
| HumanPheno | Megacolon | 2.56e-04 | 150 | 44 | 7 | HP:6000852 | |
| HumanPheno | Abnormal autonomic nervous system morphology | 2.67e-04 | 151 | 44 | 7 | HP:0012331 | |
| HumanPheno | Abnormal enteric nervous system morphology | 2.67e-04 | 151 | 44 | 7 | HP:0025028 | |
| HumanPheno | Abnormality of cranial sutures | FLNA MYH3 PSAT1 ERCC3 NSD1 TOGARAM1 RREB1 POLR3A HIRA BMP4 SETBP1 | 3.34e-04 | 388 | 44 | 11 | HP:0011329 |
| HumanPheno | Micrognathia | FLNA MYH3 PSAT1 ERCC3 EMC1 NSD1 RREB1 CBL MADD POLR3A HIRA BMP4 SETD2 UBE2T BRCA2 SETBP1 TNNT3 | 3.58e-04 | 843 | 44 | 17 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | FLNA MYH3 PSAT1 ERCC3 EMC1 NSD1 RREB1 CBL MADD POLR3A HIRA BMP4 SETD2 UBE2T BRCA2 SETBP1 TNNT3 | 3.68e-04 | 845 | 44 | 17 | HP:0009118 |
| HumanPheno | Epicanthus | FLNA MYH3 ERCC3 RREB1 CBL YWHAE MADD HIRA DDX11 GREB1L NBAS BMP4 UBE2T BRCA2 | 4.24e-04 | 614 | 44 | 14 | HP:0000286 |
| HumanPheno | Sacrococcygeal teratoma | 4.33e-04 | 4 | 44 | 2 | HP:0030736 | |
| HumanPheno | Abnormal morphology of the radius | 4.48e-04 | 217 | 44 | 8 | HP:0002818 | |
| HumanPheno | Astigmatism | 4.48e-04 | 217 | 44 | 8 | HP:0000483 | |
| HumanPheno | Abnormal eyelid morphology | FLNA MYH3 PSAT1 ABCA1 ERCC3 NSD1 APOB RREB1 CBL YWHAE MADD POLR3A HIRA DDX11 GREB1L NBAS BMP4 SETD2 UBE2T BRCA2 EGFR LPL SETBP1 | 4.49e-04 | 1408 | 44 | 23 | HP:0000492 |
| HumanPheno | Finger syndactyly | 4.62e-04 | 218 | 44 | 8 | HP:0006101 | |
| HumanPheno | Abnormal systemic arterial morphology | FLNA MYH3 ABCA1 ERCC3 NSD1 APOB RREB1 GDF2 CBL HIRA UBE2T BRCA2 EGFR TKT LPL | 5.48e-04 | 708 | 44 | 15 | HP:0011004 |
| HumanPheno | Abnormal anus morphology | 5.54e-04 | 224 | 44 | 8 | HP:0034915 | |
| HumanPheno | Anterior bulging of the globe | 5.62e-04 | 283 | 44 | 9 | HP:0000644 | |
| HumanPheno | Large face | 5.62e-04 | 283 | 44 | 9 | HP:0100729 | |
| HumanPheno | Proptosis | 5.62e-04 | 283 | 44 | 9 | HP:0000520 | |
| HumanPheno | Spina bifida | 5.70e-04 | 171 | 44 | 7 | HP:0002414 | |
| HumanPheno | Advanced eruption of teeth | 6.07e-04 | 46 | 44 | 4 | HP:0006288 | |
| Domain | LRRC37AB_C | 2.59e-06 | 4 | 163 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 2.59e-06 | 4 | 163 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.59e-06 | 4 | 163 | 3 | IPR032754 | |
| Domain | LRRC37 | 2.59e-06 | 4 | 163 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.59e-06 | 4 | 163 | 3 | IPR015753 | |
| Domain | DUF4599 | 2.62e-06 | 12 | 163 | 4 | PF15371 | |
| Domain | DUF4599 | 2.62e-06 | 12 | 163 | 4 | IPR027970 | |
| Domain | IG_FLMN | 7.49e-05 | 10 | 163 | 3 | SM00557 | |
| Domain | Transketolase_BS | 7.57e-05 | 2 | 163 | 2 | IPR020826 | |
| Domain | Filamin | 1.02e-04 | 11 | 163 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.02e-04 | 11 | 163 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.02e-04 | 11 | 163 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.02e-04 | 11 | 163 | 3 | IPR017868 | |
| Domain | Transketolase_N | 2.26e-04 | 3 | 163 | 2 | PF00456 | |
| Domain | Transketolase_N | 2.26e-04 | 3 | 163 | 2 | IPR005474 | |
| Domain | TRANSKETOLASE_1 | 2.26e-04 | 3 | 163 | 2 | PS00801 | |
| Domain | TRANSKETOLASE_2 | 2.26e-04 | 3 | 163 | 2 | PS00802 | |
| Domain | AWS | 7.44e-04 | 5 | 163 | 2 | SM00570 | |
| Domain | Transketolase_C | 7.44e-04 | 5 | 163 | 2 | IPR033248 | |
| Domain | Transketolase_fam | 7.44e-04 | 5 | 163 | 2 | IPR033247 | |
| Domain | AWS | 7.44e-04 | 5 | 163 | 2 | PS51215 | |
| Domain | AWS_dom | 7.44e-04 | 5 | 163 | 2 | IPR006560 | |
| Domain | Transketo_C/PFOR_II | 7.44e-04 | 5 | 163 | 2 | IPR009014 | |
| Domain | Transketolase_C | 7.44e-04 | 5 | 163 | 2 | PF02780 | |
| Domain | - | 7.44e-04 | 5 | 163 | 2 | 3.40.50.920 | |
| Pubmed | 7.45e-09 | 6 | 166 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 7.45e-09 | 6 | 166 | 4 | 25930072 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZC3H14 FLNA FLNC ERCC3 COPA ACOT9 STRBP CNOT10 HMMR OLA1 HIRA TKT GKAP1 DCLRE1A SPATS2 NOP2 DHX29 HDLBP | 1.37e-08 | 724 | 166 | 18 | 36232890 |
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 22419166 | ||
| Pubmed | TPTE STRBP NSD1 YWHAE POLR3A GCNT7 BRD2 UBE2T EGFR LIPM MAP4K1 ATP2C2 POC1B GALNT5 MMP12 TUBE1 | 4.92e-07 | 730 | 166 | 16 | 34857952 | |
| Pubmed | EMC1 ORC3 ACOT9 STRBP DIDO1 BTAF1 HMMR MADD POLR3A SLC30A5 TRAM1 LPL CLSPN FIGNL1 DDX11L8 | 6.00e-07 | 650 | 166 | 15 | 38777146 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | IPO5 ZC3H14 KIF18A MYH3 ERCC3 CNOT10 DIDO1 PARP14 HIRA KNOP1 BAIAP2L1 SPATS2 | 7.31e-07 | 410 | 166 | 12 | 26949251 |
| Pubmed | ZC3H14 FLNA COPA STRBP HNRNPA3 DIDO1 APOB HNRNPA2B1 SETD2 BRCA2 ODR4 GALNT5 NOP2 IMMT MAP3K19 HDLBP | 7.52e-07 | 754 | 166 | 16 | 35906200 | |
| Pubmed | ZC3H14 ERCC3 EMC1 ORC3 CNOT10 HIP1R NSD1 DIDO1 HMMR OLA1 YWHAE HIRA KNOP1 GREB1L SETD2 BRD2 UBP1 TRAM1 SPATS2 DHX29 IMMT TARBP2 HDLBP | 7.93e-07 | 1497 | 166 | 23 | 31527615 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZC3H14 FLNA CWF19L2 BAZ2B STRBP HNRNPA3 NSD1 DIDO1 RREB1 YWHAE HNRNPA2B1 KNOP1 SETD2 BRD2 BRCA2 NOP2 IMMT HDLBP | 8.06e-07 | 954 | 166 | 18 | 36373674 |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 12006559 | ||
| Pubmed | 3.42e-06 | 22 | 166 | 4 | 23247143 | ||
| Pubmed | 3.69e-06 | 7 | 166 | 3 | 22888118 | ||
| Pubmed | 4.94e-06 | 24 | 166 | 4 | 32212159 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA COPA DIDO1 BTAF1 RREB1 HNRNPA2B1 SETD2 BRD2 EGFR TKT MAP4K1 ZBTB40 NOP2 DHX29 HDLBP | 5.08e-06 | 774 | 166 | 15 | 15302935 |
| Pubmed | Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. | 5.88e-06 | 8 | 166 | 3 | 15135251 | |
| Pubmed | ZC3H14 FLNA BAZ2B ORC3 HNRNPA3 GBE1 DIDO1 HMMR OLA1 GMEB2 RREB1 HNRNPA2B1 TNRC18 RESF1 TKT ZBTB40 NOP2 HDLBP | 6.10e-06 | 1103 | 166 | 18 | 34189442 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | IPO5 FLNA FLNC EMC1 COPA ACOT9 HNRNPA3 GBE1 CBL YWHAE HNRNPA2B1 SLC30A5 EGFR ODR4 TKT TRAM1 NEIL3 HAGH POGLUT2 IMMT HDLBP | 6.28e-06 | 1451 | 166 | 21 | 30550785 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | FLNA MYH3 PSAT1 ARMC3 VPS4B APAF1 GBE1 ABCC11 SCEL OLA1 RREB1 GDF2 YWHAE BAIAP2L1 TKT ATP6V1C2 FIGNL1 | 8.12e-06 | 1016 | 166 | 17 | 19056867 |
| Pubmed | Polymorphisms associated with cholesterol and risk of cardiovascular events. | 8.78e-06 | 9 | 166 | 3 | 18354102 | |
| Pubmed | 8.78e-06 | 9 | 166 | 3 | 19773416 | ||
| Pubmed | IPO5 FLNA COPA ACOT9 HNRNPA3 HIP1R OLA1 PARP14 HNRNPA2B1 ITIH2 TKT NOP2 IMMT HDLBP | 8.89e-06 | 711 | 166 | 14 | 33022573 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ZC3H14 FLNA ERCC3 COPA ACOT9 HNRNPA3 DIDO1 HMMR YWHAE HNRNPA2B1 ITIH2 KNOP1 BAIAP2L1 EGFR TKT SPATS2 NOP2 IMMT HDLBP | 9.82e-06 | 1257 | 166 | 19 | 36526897 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | KIF18A FLNA FLNC CWF19L2 ERCC3 HMMR GMEB2 HIRA RESF1 BRCA2 HDLBP | 1.04e-05 | 444 | 166 | 11 | 34795231 |
| Pubmed | IPO5 FLNA EMC1 COPA CNOT10 ARFIP1 YWHAE SLC30A5 SNX6 SEC23IP HDLBP | 1.15e-05 | 449 | 166 | 11 | 31732153 | |
| Pubmed | 1.25e-05 | 10 | 166 | 3 | 23064749 | ||
| Pubmed | 1.36e-05 | 225 | 166 | 8 | 31478661 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ZC3H14 KIF18A ERCC3 COPA STRBP HNRNPA3 DIDO1 HMMR HNRNPA2B1 KNOP1 SPATS2 NOP2 DHX29 TARBP2 | 1.84e-05 | 759 | 166 | 14 | 35915203 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | COPA STRBP YWHAE MADD RPS6KC1 UBP1 SPATS2 NOP2 DHX29 IMMT HDLBP | 1.94e-05 | 475 | 166 | 11 | 31040226 |
| Pubmed | Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. | 2.08e-05 | 34 | 166 | 4 | 19060911 | |
| Pubmed | 2.16e-05 | 174 | 166 | 7 | 35031058 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 33811466 | ||
| Pubmed | Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes. | 2.26e-05 | 2 | 166 | 2 | 16419488 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 15735736 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28694219 | ||
| Pubmed | Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells. | 2.26e-05 | 2 | 166 | 2 | 31617054 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 10679933 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 2.26e-05 | 2 | 166 | 2 | 24469451 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 12754251 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 26474280 | ||
| Pubmed | RASopathy-associated CBL germline mutations cause aberrant ubiquitylation and trafficking of EGFR. | 2.26e-05 | 2 | 166 | 2 | 25178484 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 23693078 | ||
| Pubmed | Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes. | 2.26e-05 | 2 | 166 | 2 | 16989840 | |
| Pubmed | Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. | 2.26e-05 | 2 | 166 | 2 | 18157086 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 9121472 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 20826743 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28754676 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 19947936 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 28198003 | ||
| Pubmed | BMP signaling induces visceral endoderm differentiation of XEN cells and parietal endoderm. | 2.26e-05 | 2 | 166 | 2 | 22027433 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 31060750 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 14634011 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 25348515 | ||
| Pubmed | The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. | 2.26e-05 | 2 | 166 | 2 | 10428778 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 29272322 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 21772844 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 7689010 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22591401 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 16105874 | ||
| Pubmed | Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII. | 2.26e-05 | 2 | 166 | 2 | 16969069 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 19213840 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 20099167 | ||
| Pubmed | Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases. | 2.26e-05 | 2 | 166 | 2 | 33323455 | |
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 30076206 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22252323 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 23118983 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 36442735 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 19578043 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 23261987 | ||
| Pubmed | 2.26e-05 | 2 | 166 | 2 | 22394513 | ||
| Pubmed | 2.33e-05 | 35 | 166 | 4 | 23936387 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | IPO5 COPA ORC3 HNRNPA3 HIP1R BTAF1 OLA1 ARFIP1 YWHAE HNRNPA2B1 BRD2 HDLBP | 2.54e-05 | 582 | 166 | 12 | 20467437 |
| Pubmed | IPO5 FLNA FLNC COPA HNRNPA3 HMMR YWHAE HNRNPA2B1 TKT SEC23IP NOP2 | 2.78e-05 | 494 | 166 | 11 | 26831064 | |
| Pubmed | IPO5 ZC3H14 FLNA PSAT1 ERCC3 COPA ACOT9 VPS4B HNRNPA3 HMMR OLA1 YWHAE HNRNPA2B1 BMP4 TNRC18 SPATS2 IMMT HDLBP | 3.13e-05 | 1247 | 166 | 18 | 27684187 | |
| Pubmed | FLNA ERCC3 COPA STRBP DAB1 DIDO1 APOB HMMR OLA1 YWHAE HNRNPA2B1 ITIH2 KNOP1 TKT HAGH SPATS2 NOP2 TARBP2 HDLBP | 3.24e-05 | 1371 | 166 | 19 | 36244648 | |
| Pubmed | 3.29e-05 | 331 | 166 | 9 | 20634891 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | IPO5 ZC3H14 FLNA FLNC EMC1 COPA STRBP HNRNPA3 BTAF1 OLA1 YWHAE HNRNPA2B1 BRD2 NOP2 IMMT HDLBP | 3.47e-05 | 1024 | 166 | 16 | 24711643 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | IPO5 BAZ2B NSD1 DIDO1 BTAF1 RREB1 HIRA KNOP1 BRD2 ZBTB40 ZBTB10 NOP2 | 3.88e-05 | 608 | 166 | 12 | 36089195 |
| Pubmed | 3.92e-05 | 191 | 166 | 7 | 33762435 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZC3H14 FLNA PSAT1 DIDO1 BTAF1 NUDCD3 ARFIP1 RTN1 KNOP1 SETD2 TKT SEC23IP NOP2 DHX29 HDLBP | 4.52e-05 | 934 | 166 | 15 | 33916271 |
| Pubmed | 4.66e-05 | 15 | 166 | 3 | 26320552 | ||
| Pubmed | 4.66e-05 | 15 | 166 | 3 | 20160193 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZC3H14 COPA BAZ2B ORC3 HNRNPA3 NSD1 MECOM DIDO1 RREB1 HNRNPA2B1 HIRA KNOP1 SETD2 BRD2 UBP1 TRAM1 DCLRE1A NOP2 | 5.04e-05 | 1294 | 166 | 18 | 30804502 |
| Pubmed | 5.16e-05 | 437 | 166 | 10 | 20562859 | ||
| Pubmed | 5.34e-05 | 43 | 166 | 4 | 20565774 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.59e-05 | 202 | 166 | 7 | 33005030 | |
| Pubmed | Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery. | 5.71e-05 | 16 | 166 | 3 | 17855807 | |
| Pubmed | 5.71e-05 | 16 | 166 | 3 | 20691829 | ||
| Pubmed | 5.81e-05 | 276 | 166 | 8 | 28319085 | ||
| Pubmed | FLNA MYH3 FLNC PCDHGC5 ARMC3 COPA STRBP HNRNPA3 APOB TKTL1 HNRNPA2B1 KNOP1 RPS6KC1 DDX11 TNRC18 BRD2 TKT SEC23IP IMMT | 6.36e-05 | 1442 | 166 | 19 | 35575683 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 6.59e-05 | 281 | 166 | 8 | 30455355 | |
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 12604776 | ||
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 15696473 | ||
| Pubmed | Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling. | 6.77e-05 | 3 | 166 | 2 | 16914641 | |
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 18070883 | ||
| Pubmed | Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway. | 6.77e-05 | 3 | 166 | 2 | 27903975 | |
| Pubmed | Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling. | 6.77e-05 | 3 | 166 | 2 | 17486068 | |
| Pubmed | Recurrent gain-of-function USP8 mutations in Cushing's disease. | 6.77e-05 | 3 | 166 | 2 | 25675982 | |
| Pubmed | ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR. | 6.77e-05 | 3 | 166 | 2 | 23158001 | |
| Pubmed | 6.77e-05 | 3 | 166 | 2 | 23897813 | ||
| Cytoband | 10q22-q23 | 1.29e-04 | 5 | 166 | 2 | 10q22-q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 3.59e-04 | 8 | 166 | 2 | chr9q12 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | IPO5 KIF18A PHF19 STRBP HNRNPA3 SYT9 HMMR DDX11 GREB1L FOXRED2 BRCA2 RALGPS1 NEIL3 CLSPN TUBE1 FIGNL1 DDX11L8 | 1.51e-06 | 680 | 165 | 17 | MM456 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | IPO5 KIF18A CWF19L2 ZBTB38 GPBP1 BAZ2B ZNF268 ORC3 STRBP HMMR ITGB3BP RPS6KC1 RESF1 SLC30A5 GKAP1 DHX29 | 4.27e-06 | 656 | 165 | 16 | M18979 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 2.55e-05 | 187 | 165 | 8 | M2984 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | ZBTB38 GPBP1 ORC3 STRBP VPS4B HNRNPA3 TRMT11 TOGARAM1 OLA1 ITGB3BP BCLAF3 SNX6 GKAP1 | 2.89e-05 | 523 | 165 | 13 | M12707 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | ZBTB38 GPBP1 ORC3 STRBP VPS4B HNRNPA3 TRMT11 TOGARAM1 OLA1 ITGB3BP BCLAF3 SNX6 GKAP1 | 3.58e-05 | 534 | 165 | 13 | MM1054 |
| Coexpression | GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP | 3.70e-05 | 197 | 165 | 8 | M8159 | |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN | 3.70e-05 | 197 | 165 | 8 | M7683 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN | 4.12e-05 | 200 | 165 | 8 | M5081 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN | 4.12e-05 | 200 | 165 | 8 | M8956 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | KIF18A PHF19 HMMR GALNT18 ITGB3BP DDX11 UBE2T BRCA2 NEIL3 CLSPN | 1.58e-09 | 180 | 166 | 10 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-08 | 175 | 166 | 9 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-08 | 199 | 166 | 9 | 4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 6.56e-08 | 200 | 166 | 9 | 31dd81df9aa754a1e69b905bf9b8ce73ff8175aa | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 6.56e-08 | 200 | 166 | 9 | 54174a485a82480726fa06efa6e050ddea77cb3c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.69e-07 | 161 | 166 | 8 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.69e-07 | 161 | 166 | 8 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.69e-07 | 161 | 166 | 8 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.69e-07 | 161 | 166 | 8 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-07 | 163 | 166 | 8 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-07 | 171 | 166 | 8 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-07 | 175 | 166 | 8 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 5.72e-07 | 189 | 166 | 8 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.72e-07 | 189 | 166 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 6.19e-07 | 191 | 166 | 8 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.97e-07 | 194 | 166 | 8 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.53e-07 | 196 | 166 | 8 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.12e-07 | 198 | 166 | 8 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 8.12e-07 | 198 | 166 | 8 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | MNPs-Dividing_Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id | 8.44e-07 | 199 | 166 | 8 | 5952980d0ece5d73f3e9f340c56a38b34d2f2309 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.76e-07 | 200 | 166 | 8 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.76e-07 | 200 | 166 | 8 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 8.76e-07 | 200 | 166 | 8 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells-Neuroepithelial_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.76e-07 | 200 | 166 | 8 | c865efaaaecccbf9c833d6c1cbe85809a3ec306d | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 8.76e-07 | 200 | 166 | 8 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.76e-07 | 200 | 166 | 8 | 87e293c0882e2754756a2210a6c04723dc89f81b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-07 | 200 | 166 | 8 | 28c702449040ac15fe4e0c6340bb6f137e88539d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.76e-07 | 200 | 166 | 8 | 2ee167b8bddd11fd5b1f61f87fcdf757aee3193e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.76e-07 | 200 | 166 | 8 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.76e-07 | 200 | 166 | 8 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-06 | 156 | 166 | 7 | b3f10cd044f24807576e7d56e51df7064dbf6c50 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 158 | 166 | 7 | ee8ce3cd202807df692b28bb1a81827d49d73862 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-06 | 167 | 166 | 7 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.42e-06 | 169 | 166 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.84e-06 | 172 | 166 | 7 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.99e-06 | 173 | 166 | 7 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-06 | 175 | 166 | 7 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-06 | 180 | 166 | 7 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.37e-06 | 181 | 166 | 7 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.57e-06 | 182 | 166 | 7 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 5.78e-06 | 183 | 166 | 7 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.78e-06 | 183 | 166 | 7 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.98e-06 | 69 | 166 | 5 | 54e5ede00ce2920158d1cc0ac8e718aa24a4342e | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.98e-06 | 69 | 166 | 5 | c93a47ee777b560f69b705d5d597f3cb3a3f558a | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.98e-06 | 69 | 166 | 5 | 8946d7e433c232c56563a6c464152c0a8cdbdf92 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.99e-06 | 184 | 166 | 7 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.99e-06 | 184 | 166 | 7 | a0831e850bc0b585296ed350fdd075c1f730308e | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.89e-06 | 188 | 166 | 7 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.13e-06 | 189 | 166 | 7 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-06 | 189 | 166 | 7 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-06 | 189 | 166 | 7 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.38e-06 | 190 | 166 | 7 | b69940d16685249167d4c2cf6ad8237ccf6f7590 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.38e-06 | 190 | 166 | 7 | cd37ccd30c27cf65eda0a9165f35b7672f5acaf6 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.64e-06 | 191 | 166 | 7 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.64e-06 | 191 | 166 | 7 | ff2cc4c10aa584b3daeaaf23cd8ee09bdbdf684d | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.64e-06 | 191 | 166 | 7 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.90e-06 | 192 | 166 | 7 | 3856c4d611224cd6c2558631147cd5333bc0ccb7 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 8.18e-06 | 193 | 166 | 7 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.18e-06 | 193 | 166 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.46e-06 | 194 | 166 | 7 | e5b81a8e52259a54a911c1c2ac932c98c988318d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 194 | 166 | 7 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 8.46e-06 | 194 | 166 | 7 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.46e-06 | 194 | 166 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.46e-06 | 194 | 166 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.74e-06 | 195 | 166 | 7 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.04e-06 | 196 | 166 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.35e-06 | 197 | 166 | 7 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 9.35e-06 | 197 | 166 | 7 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | mild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.35e-06 | 197 | 166 | 7 | 21085d5e27b5a23a241a933058bb89f8a1fcf198 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 9.66e-06 | 198 | 166 | 7 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.66e-06 | 198 | 166 | 7 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 9.66e-06 | 198 | 166 | 7 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.66e-06 | 198 | 166 | 7 | 6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.66e-06 | 198 | 166 | 7 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.66e-06 | 198 | 166 | 7 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.66e-06 | 198 | 166 | 7 | 8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.66e-06 | 198 | 166 | 7 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 9.66e-06 | 198 | 166 | 7 | dada1c19a261c8e1090957cd7e37f2a43a9fe14f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.66e-06 | 198 | 166 | 7 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 9.98e-06 | 199 | 166 | 7 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.98e-06 | 199 | 166 | 7 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 9.98e-06 | 199 | 166 | 7 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.98e-06 | 199 | 166 | 7 | 88d130e2451e61afb710edf552e6b346b9fcfb2b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.98e-06 | 199 | 166 | 7 | f315ec3fb6c0799668c9195f836a77fc0db2b615 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.98e-06 | 199 | 166 | 7 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | 9.98e-06 | 199 | 166 | 7 | 5c755b6876e164dc847ef7c723f850f227cf3a87 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.98e-06 | 199 | 166 | 7 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.98e-06 | 199 | 166 | 7 | 616c04b0605907fb218263f2164c36cb2fa26b87 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.98e-06 | 199 | 166 | 7 | 2fbf94f7858250088e0f5ce1ff51892730a13ae8 | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 9.98e-06 | 199 | 166 | 7 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | (1)_T_cells-(1)_T_cell_dividing|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 9.98e-06 | 199 | 166 | 7 | 33afdd1b1b951b360ababf440bc556fd9e1c1db2 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.98e-06 | 199 | 166 | 7 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.03e-05 | 200 | 166 | 7 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.03e-05 | 200 | 166 | 7 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.03e-05 | 200 | 166 | 7 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.03e-05 | 200 | 166 | 7 | 2938a029fa0478be561574ace91f95c4a528b2d4 | |
| ToppCell | distal-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.03e-05 | 200 | 166 | 7 | 0cd3b01fb7f579e5abf000adb8ec8adc7cd779c4 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-05 | 200 | 166 | 7 | 535f6fba8d03873ba35c9949579161dc41cd7a60 | |
| ToppCell | Severe_COVID-19-T/NK-proliferating_T/NK|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.03e-05 | 200 | 166 | 7 | 52265e761a961f3724b388285e0919bd58847138 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-05 | 200 | 166 | 7 | 97e47eb69d1d4cab45256acca9589837eb7817e7 | |
| Disease | Malignant neoplasm of breast | TPTE FLNA ERCC3 STRBP LRRC37A2 GSDMB TRMT11 MECOM HMMR OLA1 BMP4 SETD2 LRRC37A BRCA2 EGFR SETBP1 GALNT5 CLSPN HDLBP | 4.31e-06 | 1074 | 156 | 19 | C0006142 |
| Disease | myopathy (implicated_via_orthology) | 5.52e-06 | 48 | 156 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B (is_implicated_in) | 2.78e-05 | 2 | 156 | 2 | DOID:0111599 (is_implicated_in) | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.87e-05 | 67 | 156 | 5 | C3463824 | |
| Disease | Hyperlipoproteinemia Type IIb | 3.99e-05 | 13 | 156 | 3 | C1704417 | |
| Disease | Hyperlipoproteinemia Type IIa | 7.72e-05 | 16 | 156 | 3 | C0745103 | |
| Disease | triglycerides in large LDL measurement | 7.90e-05 | 43 | 156 | 4 | EFO_0022319 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 8.30e-05 | 3 | 156 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 8.30e-05 | 3 | 156 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 8.30e-05 | 3 | 156 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | Hypercholesterolemia, Familial | 1.12e-04 | 18 | 156 | 3 | C0020445 | |
| Disease | Mammary Carcinoma, Human | FLNA LRRC37A2 TRMT11 MECOM HMMR BMP4 SETD2 LRRC37A BRCA2 EGFR SETBP1 | 1.17e-04 | 525 | 156 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | FLNA LRRC37A2 TRMT11 MECOM HMMR BMP4 SETD2 LRRC37A BRCA2 EGFR SETBP1 | 1.17e-04 | 525 | 156 | 11 | C1257931 |
| Disease | Mammary Neoplasms | FLNA LRRC37A2 TRMT11 MECOM HMMR BMP4 SETD2 LRRC37A BRCA2 EGFR SETBP1 | 1.21e-04 | 527 | 156 | 11 | C1458155 |
| Disease | Breast Carcinoma | FLNA LRRC37A2 TRMT11 MECOM HMMR BMP4 SETD2 LRRC37A BRCA2 EGFR SETBP1 | 1.44e-04 | 538 | 156 | 11 | C0678222 |
| Disease | free cholesterol in large LDL measurement | 1.55e-04 | 51 | 156 | 4 | EFO_0022176 | |
| Disease | Sheldon-Hall syndrome | 1.65e-04 | 4 | 156 | 2 | cv:C1834523 | |
| Disease | Noonan syndrome (implicated_via_orthology) | 1.65e-04 | 4 | 156 | 2 | DOID:3490 (implicated_via_orthology) | |
| Disease | Sotos' syndrome | 1.65e-04 | 4 | 156 | 2 | C0175695 | |
| Disease | tuberous sclerosis (is_marker_for) | 1.65e-04 | 4 | 156 | 2 | DOID:13515 (is_marker_for) | |
| Disease | colorectal cancer (is_marker_for) | 1.94e-04 | 157 | 156 | 6 | DOID:9256 (is_marker_for) | |
| Disease | triglycerides in LDL measurement | 2.23e-04 | 56 | 156 | 4 | EFO_0022320 | |
| Disease | Malignant Cystosarcoma Phyllodes | 2.75e-04 | 5 | 156 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 2.75e-04 | 5 | 156 | 2 | C0010701 | |
| Disease | Myelomonocytic leukemia | 2.75e-04 | 5 | 156 | 2 | C0027019 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 2.91e-04 | 60 | 156 | 4 | EFO_0022282 | |
| Disease | high density lipoprotein particle size measurement | 2.98e-04 | 170 | 156 | 6 | EFO_0008592 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 3.24e-04 | 321 | 156 | 8 | EFO_0004612, EFO_0004639 | |
| Disease | Leukemia, Myelocytic, Acute | 3.27e-04 | 173 | 156 | 6 | C0023467 | |
| Disease | triglycerides in medium LDL measurement | 3.30e-04 | 62 | 156 | 4 | EFO_0022322 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 3.58e-04 | 114 | 156 | 5 | EFO_0004529, EFO_0004611 | |
| Disease | Digitotalar Dysmorphism | 4.11e-04 | 6 | 156 | 2 | C1852085 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 4.11e-04 | 6 | 156 | 2 | C0220662 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 4.11e-04 | 6 | 156 | 2 | C1834523 | |
| Disease | total lipids in very large HDL measurement | 4.20e-04 | 66 | 156 | 4 | EFO_0022312 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 4.45e-04 | 67 | 156 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | Miller Dieker syndrome | 4.79e-04 | 29 | 156 | 3 | C0265219 | |
| Disease | cholesterol in very large HDL measurement | 4.97e-04 | 69 | 156 | 4 | EFO_0022229 | |
| Disease | HMG CoA reductase inhibitor use measurement | 5.23e-04 | 189 | 156 | 6 | EFO_0009932 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 5.66e-04 | 126 | 156 | 5 | EFO_0004611, EFO_0010351 | |
| Disease | myeloid neoplasm (is_implicated_in) | 5.73e-04 | 7 | 156 | 2 | DOID:0070004 (is_implicated_in) | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 5.84e-04 | 31 | 156 | 3 | EFO_0022249 | |
| Disease | total lipids in large HDL | 6.49e-04 | 74 | 156 | 4 | EFO_0022189 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 7.62e-04 | 8 | 156 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | Unilateral agenesis of kidney | 7.62e-04 | 8 | 156 | 2 | C0266294 | |
| Disease | Adenocarcinoma of lung (disorder) | 8.21e-04 | 206 | 156 | 6 | C0152013 | |
| Disease | free cholesterol in large HDL measurement | 8.30e-04 | 79 | 156 | 4 | EFO_0022157 | |
| Disease | Schizophrenia | IPO5 IL10RA DLGAP1 PSAT1 ABCA1 LAMA1 HNRNPA3 YWHAE FBXL21P EGR3 LPL KCNQ3 HAGH | 8.65e-04 | 883 | 156 | 13 | C0036341 |
| Disease | cholesterol in large HDL measurement | 8.70e-04 | 80 | 156 | 4 | EFO_0021900 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 8.82e-04 | 139 | 156 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Distal arthrogryposis | 9.76e-04 | 9 | 156 | 2 | cv:C0265213 | |
| Disease | 22q11 partial monosomy syndrome | 9.76e-04 | 9 | 156 | 2 | C3266101 | |
| Disease | Cancer of Nasopharynx | 9.76e-04 | 9 | 156 | 2 | C0238301 | |
| Disease | Nasopharyngeal Neoplasms | 9.76e-04 | 9 | 156 | 2 | C0027439 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 9.87e-04 | 37 | 156 | 3 | EFO_0022252 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.14e-03 | 301 | 156 | 7 | DOID:684 (is_marker_for) | |
| Disease | Hypercholesterolemia | 1.15e-03 | 39 | 156 | 3 | C0020443 | |
| Disease | Asymmetric crying face association | 1.22e-03 | 10 | 156 | 2 | C0431406 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 1.22e-03 | 10 | 156 | 2 | OBA_2045163 | |
| Disease | 22q11 Deletion Syndrome | 1.22e-03 | 10 | 156 | 2 | C2936346 | |
| Disease | ciliopathy (implicated_via_orthology) | 1.24e-03 | 40 | 156 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.28e-03 | 307 | 156 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | Colonic Neoplasms | 1.31e-03 | 152 | 156 | 5 | C0009375 | |
| Disease | osteosarcoma (is_marker_for) | 1.48e-03 | 11 | 156 | 2 | DOID:3347 (is_marker_for) | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 1.58e-03 | 94 | 156 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | Malignant tumor of colon | 1.60e-03 | 159 | 156 | 5 | C0007102 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 1.71e-03 | 96 | 156 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | total lipids in very small VLDL measurement | 1.75e-03 | 45 | 156 | 3 | EFO_0022156 | |
| Disease | QRS complex, QRS duration | 1.75e-03 | 45 | 156 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | Malignant neoplasm of kidney | 1.75e-03 | 45 | 156 | 3 | C0740457 | |
| Disease | saturated fatty acids measurement | 1.75e-03 | 45 | 156 | 3 | EFO_0022304 | |
| Disease | peptic esophagitis (biomarker_via_orthology) | 1.77e-03 | 12 | 156 | 2 | DOID:13976 (biomarker_via_orthology) | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 1.77e-03 | 12 | 156 | 2 | C0403553 | |
| Disease | integral membrane protein 2B measurement | 1.77e-03 | 12 | 156 | 2 | EFO_0802634 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 1.92e-03 | 99 | 156 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 1.93e-03 | 330 | 156 | 7 | EFO_0004529, EFO_0004612 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.93e-03 | 166 | 156 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | Celiac Disease | 1.98e-03 | 47 | 156 | 3 | C0007570 | |
| Disease | free cholesterol in small VLDL measurement | 1.98e-03 | 47 | 156 | 3 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 1.98e-03 | 47 | 156 | 3 | EFO_0022275 | |
| Disease | free cholesterol in medium VLDL measurement | 1.98e-03 | 47 | 156 | 3 | EFO_0022269 | |
| Disease | coronary artery disease (is_implicated_in) | 1.99e-03 | 100 | 156 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.06e-03 | 101 | 156 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.09e-03 | 169 | 156 | 5 | DOID:3908 (is_marker_for) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.23e-03 | 49 | 156 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 2.23e-03 | 49 | 156 | 3 | EFO_0021897 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 2.29e-03 | 104 | 156 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | free cholesterol in LDL measurement | 2.37e-03 | 50 | 156 | 3 | EFO_0022266 | |
| Disease | femoral neck bone geometry | 2.42e-03 | 14 | 156 | 2 | EFO_0004511 | |
| Disease | sitting height ratio | 2.51e-03 | 51 | 156 | 3 | EFO_0007118 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 2.51e-03 | 51 | 156 | 3 | EFO_0022285 | |
| Disease | phospholipids in medium VLDL measurement | 2.65e-03 | 52 | 156 | 3 | EFO_0022154 | |
| Disease | total lipids in LDL measurement | 2.65e-03 | 52 | 156 | 3 | EFO_0022308 | |
| Disease | low density lipoprotein triglyceride measurement | 2.79e-03 | 15 | 156 | 2 | EFO_0009946 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 2.79e-03 | 15 | 156 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | Replication Error Phenotype | 2.79e-03 | 15 | 156 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 2.79e-03 | 15 | 156 | 2 | C0920269 | |
| Disease | triacylglycerol 52:3 measurement | 2.79e-03 | 15 | 156 | 2 | EFO_0010415 | |
| Disease | infant head circumference | 2.79e-03 | 15 | 156 | 2 | EFO_0004577 | |
| Disease | Hypertriglyceridemia | 2.79e-03 | 15 | 156 | 2 | C0020557 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGGTISSELKHKIKF | 291 | Q8NAT2 | |
| QKTAHPLGVKLVFSK | 311 | Q9H6B1 | |
| KHLIPAANTGESKVF | 106 | P62258 | |
| NGTNLKKIHVSPDFK | 1216 | O14727 | |
| SPFDHKKTVSGFQKL | 146 | Q9Y6F7 | |
| SLKTKAFQAHTPAQK | 1196 | Q9UIF8 | |
| NLKDKFIKHFTGPVT | 71 | Q6UXT8 | |
| NIHFRGKTKSFPEEK | 221 | Q8TAX9 | |
| EKKLHAVPAGNTVKF | 156 | P22455 | |
| VSKAKHLQFISGVKP | 1681 | O95477 | |
| TLKQFHIKLKTPGVD | 351 | P53367 | |
| KKSLSPEQDIKFSGH | 156 | Q9Y305 | |
| KGHNPRSSIAVKLFK | 271 | P35368 | |
| QKLFTKSHSLEGPSK | 146 | O14490 | |
| LAFKKIPQKSSHAVC | 76 | Q5VSY0 | |
| KSNVIPIGHVKKGIF | 781 | Q5W041 | |
| KKHKAPAAAVVRAAV | 6 | Q7Z478 | |
| ASHASLIPETGKKKV | 21 | P12644 | |
| VGKVSVFFRTSPKHK | 641 | O75185 | |
| KAINALKSFHKPVTS | 281 | Q9UGP5 | |
| SPKEFVHLAGKSTLK | 126 | Q9UKD1 | |
| PKRTSVKKGHIQFEA | 506 | Q96L73 | |
| KKEKHSLAPNVVAFT | 81 | Q5JS13 | |
| KSIHSFGFPNFVKKI | 366 | P39900 | |
| IRKGTKAPQAAGKIH | 321 | Q9NTK5 | |
| KAPQAAGKIHTDFEK | 326 | Q9NTK5 | |
| VQTLVHLKFPTKVGK | 376 | Q9UK05 | |
| TKLTEPRKNHVFGGK | 786 | Q03112 | |
| SIEKLPVFNKSAFKH | 371 | Q16654 | |
| ATAKFHVTPLFGNVK | 211 | Q6PIW4 | |
| TTKQHKFEDLTPGKK | 1046 | P23467 | |
| HKAAVSVLKPFSKGA | 1241 | O60309 | |
| TIFGKAHSLKPSIKE | 1251 | Q8WXG6 | |
| PKIKNGKHTFSEVEV | 166 | P15529 | |
| KKVVTKTFHGTGLVP | 216 | A8MVJ9 | |
| HKAAVSVLKPFSKGA | 1241 | A6NM11 | |
| HKAAVSVLKPFSKGT | 1241 | A6NMS7 | |
| GKPHTEVKINRKTAF | 371 | Q8TAT5 | |
| SKGQQKAHVSFKPTV | 241 | P19823 | |
| PKHVVKGKQVSVALS | 206 | Q8IVD9 | |
| GVDTKAIKSFPAHLA | 541 | Q96S38 | |
| ATVKHAKSPGTKFLL | 216 | Q5VYY2 | |
| KSQTKENKVGTSFPH | 226 | Q86WP2 | |
| FFGQAIKVTHKATGK | 341 | P53671 | |
| PQKVVDAARKHGVKL | 81 | Q16775 | |
| PKQEEVSFFHGKKTT | 46 | Q8NI77 | |
| KHKKSQKGSAFTFPS | 581 | O43525 | |
| SHLQKGKAPAVFVKC | 451 | P06858 | |
| IHSSKPKVKDAVQAV | 291 | Q5SWX8 | |
| SHFSLNVKTLKDGKP | 176 | Q9Y5F6 | |
| SSQFPKHLIVAIGVK | 681 | Q2TBE0 | |
| KPTHFTVLTKGAGKA | 886 | Q14315 | |
| SVRKSGKHVTNSPFK | 2016 | Q14315 | |
| SKFPKKLHTDVVENG | 1261 | Q96J66 | |
| NAKKKEVAGAKPHIT | 311 | Q16891 | |
| HKKEKKGAQDPTAFS | 151 | Q1ED39 | |
| IRKVPGNFTFTHKKV | 171 | Q13651 | |
| TGLKFSPHLVNTVFK | 466 | Q86XE3 | |
| VQVFASGKPKISAHR | 451 | Q9H0R1 | |
| KRGKFSEFKAHTAPV | 91 | Q8TC44 | |
| QFVHEVKKSPFGKDV | 241 | Q96FC9 | |
| LAILKDSKGKFHVTP | 286 | Q8IWF2 | |
| APGFQKKFHEKVIAA | 431 | O00410 | |
| IIPKSKESHFVFSKQ | 1481 | Q9C091 | |
| EKHGLEKPISFVKNT | 1051 | A2RRP1 | |
| TKHAKVLFRASGGKP | 1101 | O75161 | |
| LNKVLGIKHFDPSKA | 676 | O75330 | |
| KSVHTDKPGAKQFFQ | 741 | Q460N5 | |
| EAQVRAAPAKKHTGK | 61 | Q8IZU1 | |
| VNKQKLFEKSTGLPH | 146 | Q13352 | |
| KTPQHVKITDFGLAK | 846 | P00533 | |
| KFSHVEKLGNNPVSK | 1436 | P04114 | |
| QLVAASKVKANKHSP | 916 | O75146 | |
| NKSVLVPHGSKLKVV | 131 | Q04446 | |
| AKKVVKTHEPASFNL | 71 | Q6UX52 | |
| KVKNVHTDGFQKPTH | 591 | A2AJT9 | |
| KQKVKTIFPHTAGSN | 341 | Q9UHR4 | |
| AGPAKVFVKIKASHA | 596 | Q96B18 | |
| HKQKIFLTISFGGIK | 81 | O75553 | |
| LLGFHTASGKKVKIA | 1521 | P51587 | |
| ETEKPKLKATGHVFQ | 1556 | O14981 | |
| KSKTSQSHLEFVPKG | 241 | Q6ZNI0 | |
| KPTHFTVNAKAAGKG | 891 | P21333 | |
| ETKSARVKGLSFHPK | 6 | P53621 | |
| IFPKVLGKSQSKHIS | 346 | Q7Z7M9 | |
| IKAFKDKQIHPGFGS | 231 | Q06889 | |
| LAQFVHEVKKSPFGK | 241 | A8MPP1 | |
| KATFGPAIAAVQKFH | 886 | A8MPP1 | |
| TGNAILGKHVFKSKF | 26 | Q8ND71 | |
| KVNSQKPGFIKVVRH | 211 | Q6P9A2 | |
| KPGFIKVVRHSKQEG | 216 | Q6P9A2 | |
| DTIPKKVVCHFSGKA | 811 | Q9NZV1 | |
| HILQTLFGKKKSFDP | 1316 | Q9BTC0 | |
| EVKARLQKFIHKPGS | 276 | P22681 | |
| HSSVQKKAKGPVHIV | 771 | Q8N766 | |
| GKLAASVHQATKAKP | 416 | Q6PJP8 | |
| NNASVKVKGPAHKIS | 126 | A6NNS2 | |
| FKHNPKINTIFISKV | 596 | P19447 | |
| GHRKAVTVVKFNPKI | 266 | P54198 | |
| FHAATTAGKLVSLPK | 201 | P20132 | |
| GTPKHFAEAKEFVKQ | 161 | Q9NV23 | |
| PKTSFGIKQEHKVLI | 726 | Q56UN5 | |
| GFIKPTKQKTDHVAR | 691 | Q9UBD5 | |
| LKIPSAAGKHKAFST | 226 | Q8NH93 | |
| VSENPGQIKFHAVKK | 266 | Q9UKT6 | |
| AFHNFIKVTLTKSPK | 246 | Q92918 | |
| VAKIQAKIPGAKRHA | 761 | Q16799 | |
| IHKAVNLPAKDFSGT | 241 | Q86SS6 | |
| ISHVPENTKGAVKKH | 231 | Q9P1P4 | |
| FQAVLLQPHKKSSTK | 361 | Q8NEY4 | |
| FEGKVNLKKPQHVFS | 136 | Q7Z4G4 | |
| VNTVPLKNKKASSFH | 46 | Q9NU19 | |
| FTFAPHKKVLTKNLS | 511 | Q8N103 | |
| KHKTFLPVKGNTEKS | 1616 | Q9HCM1 | |
| QIKKSPAVKVTHFKG | 2256 | P25391 | |
| THVKTSNLAAPKSGK | 766 | Q8IWB4 | |
| KKFGTINIVHPKLGS | 116 | Q9Y617 | |
| FEKHSKLPAAKGFVA | 821 | O14802 | |
| HFVRSQDKLKTPLGK | 86 | Q6ZNE9 | |
| ASGPSKKTAKLHVAV | 431 | Q96SI9 | |
| KPKVVKGRAEAHFSL | 566 | P11055 | |
| GPRKKIANFVEHKAA | 691 | Q9Y6Y8 | |
| HPKKASFQKLNGISK | 641 | P46087 | |
| FCKHLGGTQKTAVPK | 406 | Q8N9L9 | |
| ELVVTIPKNSHKKGA | 186 | P25440 | |
| TGKFTSQAEKHLPRK | 916 | Q9HAW4 | |
| AVKTHSEVRKKPVFQ | 711 | Q9H9A5 | |
| GKVSPTAKTKSLLHF | 11 | Q17RW2 | |
| KASHFGPFIAKKVIG | 196 | Q9BTX7 | |
| THVKTSNLAAPKSGK | 766 | Q5VYP0 | |
| TKATKQAGKARPSAH | 2701 | O15417 | |
| QPVRKVQSATHFKKV | 351 | O75351 | |
| LKKSIDSFGQVSHPK | 361 | Q86XZ4 | |
| KSILGNKKFHTGEIP | 276 | P52740 | |
| KTHSEKFQGVKTPSQ | 376 | P56180 | |
| GKAFTFKSQLIVHKG | 646 | Q14587 | |
| GHTAFLVKLRKVKPQ | 461 | Q9BVS5 | |
| ESGKPGAHVTVKKLF | 101 | P22626 | |
| AKHQPTAIIAKTFKG | 231 | P29401 | |
| THVKTSNLAAPKSGK | 766 | Q5TZJ5 | |
| THVKTSNLAAPKSGK | 766 | Q5VU36 | |
| SLLFVKKKNGLHFPS | 751 | Q9H5L6 | |
| KDSIKHLSLQPFQKG | 431 | Q92766 | |
| TSSSGALKKQHKKPF | 241 | Q9UJT0 | |
| KVEAFKGKILCQSHP | 1501 | Q6ZQQ2 | |
| HINVSPKAVKNTDGK | 471 | O95171 | |
| FIKKFLSNKPSALHG | 131 | Q6ZSR6 | |
| KKQAAPHLKAEVGNS | 416 | Q9Y5S1 | |
| RKASQLVGIEKKFHP | 181 | Q9NPD8 | |
| ATSHLPNKGALAKVK | 16 | Q5T6S3 | |
| SVKPGAHLTVKKIFV | 116 | P51991 | |
| PDKSSGKSHIEKLIF | 1291 | Q9ULM0 | |
| KVEIKFQGQHVAKSP | 111 | Q6UW63 | |
| PQTDKFFLHKGTEKN | 1126 | Q9BYW2 | |
| VKFTVHTKSSLPNFK | 46 | Q9UNH7 | |
| KSVTQQIHFKKTSGP | 196 | P10073 | |
| HSASCQIKVFKPKGA | 226 | Q9NZI7 | |
| HSAFQAPAVKKKPTV | 326 | Q15629 | |
| LFQKPFSSGKTITKH | 76 | Q8TAD4 | |
| FKSPKLAKHAAVFSG | 326 | P49910 | |
| IDQAQKHSKKAGTPA | 246 | P45378 | |
| SGKIFKAHKNILVAG | 371 | Q96DT7 | |
| QGPSKKAAKHKAAEV | 76 | Q15633 | |
| SPDHTKFVGSFKTKQ | 96 | Q9NX01 | |
| VPIFKQFHKNIIGKG | 586 | Q00341 | |
| KHLFKSPSQQEKIGD | 1146 | Q8NAP3 | |
| KKKISHIAEQSPSAG | 1066 | Q9Y4F4 | |
| FTGDTLKPKHQQKSS | 201 | Q9Y6X0 | |
| LPVVSSVVKVKKFNH | 296 | Q6PJT7 | |
| GKAFPRSSALKQHKK | 416 | Q8NCK3 | |
| QASQVKHKPTAVVAK | 201 | P51854 | |
| KHKPTAVVAKTFKGR | 206 | P51854 | |
| GKLPVGKHNFSKIIS | 81 | Q9NUA8 | |
| KIHILPTNAKVGSKF | 116 | Q9UFV3 |